NACC Pharmaceutical Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Gliminac MV 2mg/500mg/0.3mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Gliminac MV 2mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Gliminac MV 2mg/500mg/0.3mg Tablet is to be taken empty stomach.
Gliminac MV 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Gliminac MV 2mg/500mg/0.3mg Tablet is a combination medication consisting of glimepiride, metformin, and voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults by improving blood glucose levels when combined with a proper diet and regular exercise.
Common side effects associated with the use of Gliminac MV 2mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Gliminac MV 2mg/500mg/0.3mg Tablet should be avoided in patients with a known allergy to its components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
No, consuming alcohol with Gliminac MV 2mg/500mg/0.3mg Tablet may lower your blood sugar levels and increase the risk of lactic acidosis.
Yes, taking Gliminac MV 2mg/500mg/0.3mg Tablet can lead to hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. Regular monitoring of blood glucose levels is essential, especially when taking other medications or engaging in activities that lower blood sugar.
Store Gliminac MV 2mg/500mg/0.3mg Tablet in its original packaging, tightly closed, following the storage instructions provided on the label or pack. Dispose of unused medication properly to prevent consumption by pets, children, and other individuals.